Dr Lim Kheng Choon

About

 

Dr Lim Kheng Choon graduated from Duke-NUS Graduate Medical School in 2011 and is currently the Director of Brain & Spine imaging in SGH Department of Neuroradiology with interest in neuro-oncology and advanced MRI techniques.

 

He is the Deputy Director of Quality & Safety Performance Management, and help previously appointments in Clinical Operations, MRI modality; he is currently a Clinical Assistant Professor at Duke-NUS Graduate Medical School.

 

He completed a 6-month Health Manpower Development Plan Fellowship on Advance Neuroradiology Imaging and Imaging Informatics with Hospital of University of Pennsylvania Department of Radiology in 2023. During his residency training, Dr Lim was appointed Chief Resident under the Singapore Chief Resident Programme.

 

Before medicine, Dr Lim graduated with a Bachelor of Engineering (Mechanical) and worked in the Republic of Singapore Air Force as an Air Engineering Officer.

Education and Training

• Master of Medicine (Diagnostic Radiology), NUS, 2015
• Fellow of the Fellow of the Royal College of Radiologists (UK), 2015
• Doctor of Medicine, Duke-NUS Graduate Medical School, 2011
• Bachelor of Engineering (Mechnical), 2nd Class Honors (Upper) with Minor in Law, NUS, 1999
  

Professional Appointments and Committee Memberships

• Medical Advisor, Singapore Society of Radiographers
• Council Member, Singapore Medical Association (SMA)
• Director, SMA Charity Fund
  

Awards

• National Award (COVID-19) - Commendation Medal (COVID-19), 2022
• Singhealth Outstanding Chief Resident Award, 2017
• SingHealth Inspiring Resident Educator Award, 2016
• Singhealth Duke-NUS Research Team Awards 2nd Prize, 2016
• Singhealth Publish! Award (Outstanding), 2015
• Singhealth Evidence Based Medicine Prize, 2013
• David Sabiston Gold Medal for Top Surgery, 2011, Duke-NUS Graduate Medical School
  

Publications

1. Microvascular Invasion is a Better Predictor of Tumour Recurrence and Overall Survival Following Surgical Resection for Hepatocellular Carcinoma Compared to the Milan Criteria.
   Lim KC, Chow PK, Allen JC et. al.
   Annals of Surgery. 2011 Jul;254(1):108-13. PMID: 21527845.
2. Systematic Review of Outcomes of Liver Resection for Early Hepatocellular Carcinoma Within the Milan Criteria.
   Lim KC, Chow PK, Allen JC et. al.
   British Journal of Surgery. 2012, 99:1622-1629. PMID: 23023956.
3. Cost-Effectiveness Analysis of Liver Resection Versus Transplantation for Early Hepatocellular Carcinoma Within the Milan Criteria.
   Lim KC, Wang VW, Siddiqui FJ et. al.
   Hepatology. 2015 Jan; 61(1): 227-37. PMID: 24638991.
4. Radiology Preparedness in the Ongoing Battle against COVID-19: Experience from Large to Small Singapore Public Hospitals.
   Tan BP, Lim KC, Goh YG, et. al.
   Radiology: Cardiothoracic Imaging. 2020 Apr 23. 2. e200140. doi: 10.1148/ryct.2020200140.
5. A Rare Case of Acute Hemorrhagic Leukoencephalitis in a COVID-19 Patient. Yong MH, Chan YFZ, Liu J, Sanamandra SK, Kheok SW, Lim KC, Sewa DW.
   J Neurol Sci. 2020 Sep 15;416:117035. doi: 10.1016/j.jns.2020.117035.
6. Thymosin β4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction.
   Tan SH, Loo SJ, Gao Y, Tao ZH, Su LP, Wang CX, Zhang SL, Mu YH, Cui YH, Abdurrachim D, Wang WH, Lalic J, Lim KC, Bu J, Tan RS, Lee TH, Zhang J, Ye L.
   Theranostics. 2021 Jun 26;11(16):7879-7895. doi: 10.7150/thno.56757.
7. Non-Invasive Assessment of Isocitrate Dehydrogenase-Mutant Gliomas Using Optimized Proton Magnetic Resonance Spectroscopy on a Routine Clinical 3-Tesla MRI. de Godoy LL*, Lim KC*, Rajan A et. al.
   Cancers. 2023 Sep; 15(18):4453. https://doi.org/10.3390/cancers15184453
   *shared first authorship
   

Full list: https://scholar.google.com/citations?hl=en&user=vEZYU1MAAAAJ